All In MedTech

Device Trial Radar · NCT04488159

Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer

IMmunoscore Associated Decision GuIdance for AdjuvaNt Chemotherapy and Physical Exercise in Stage III Colon Cancer (iMAGINE): a Prospective, Randomized, Open-label, Multicenter, Phase III Clinical Trial

Last checked: Nov 20, 2026Latest source record: Sep 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Dec 1, 2024

Primary completion

Dec 1, 2025

Study completion Jun 1, 2026

Sponsor

Lead sponsor
Johannes Laengle, MD, PhDAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 27, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The overall aim of this study is to prospectively validate the superiority of the Immunoscore as a decision guidance for adjuvant chemotherapy in stage III colon cancer patients, in comparison to the conventional TNM-based high- or low-risk classification.

Conditions

  • Colon Cancer Stage III

Interventions

  • CapecitabineDrug

    Tablet

  • OxaliplatinDrug

    Infusion

  • FluorouracilDrug

    Infusion

  • LeucovorinDrug

    Infusion

  • Immunoscore® assayDevice

    Whole-slide tissue analysis of CD3+ and cytotoxic CD8+ T cells in the tumor and in the invasive margin

  • Physical exerciseOther

    Increasing stair walking exercise twice a week over 12 weeks total.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free survival (DFS)Time frame: 3 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical University of Vienna

    Vienna, State of Vienna, Austria

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.